Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-907.44%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00% | +100.0% |
| 2023 | -4470.81% | -137.6% |
| 2022 | -1881.28% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |